Home/Filings/4/0001534969-24-000073
4//SEC Filing

Boniface John J. 4

Accession 0001534969-24-000073

CIK 0001534969other

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 5:56 PM ET

Size

15.6 KB

Accession

0001534969-24-000073

Insider Transaction Report

Form 4
Period: 2024-03-27
Boniface John J.
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2024-03-28$0.91/sh+24,474$22,271164,245 total
  • Sale

    Class A Common Stock

    2024-03-27$9.62/sh3,753$36,104139,771 total
  • Exercise/Conversion

    Class A Common Stock

    2024-03-27$0.91/sh+48,909$44,507188,680 total
  • Sale

    Class A Common Stock

    2024-03-27$9.62/sh48,909$470,505139,771 total
  • Sale

    Class A Common Stock

    2024-03-28$9.04/sh24,474$221,245139,771 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-2748,90924,474 total
    Exercise: $0.91Exp: 2024-12-29Class A Common Stock (48,909 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-2824,4740 total
    Exercise: $0.91Exp: 2024-12-29Class A Common Stock (24,474 underlying)
Footnotes (4)
  • [F1]The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.85, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.58 to $9.24, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  • [F4]The shares subject to this option are fully vested and exercisable.

Issuer

SERA PROGNOSTICS, INC.

CIK 0001534969

Entity typeother

Related Parties

1
  • filerCIK 0001870674

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 5:56 PM ET
Size
15.6 KB